Earnings summaries and quarterly performance for DocGo.
Executive leadership at DocGo.
Board of directors at DocGo.
Research analysts who have asked questions during DocGo earnings calls.
Pito Chickering
Deutsche Bank
3 questions for DCGO
Also covers: ACHC, AHCO, AVAH +18 more
Ryan MacDonald
Needham & Company
3 questions for DCGO
Also covers: ACCD, AMWL, BNED +17 more
Aditya Dagaonkar
Northland Capital Markets
1 question for DCGO
Also covers: CTLP, GRRR, ONDS +1 more
David Grossman
Stifel
1 question for DCGO
Also covers: DH, DRIO, EPAM +3 more
David Larsen
BTIG
1 question for DCGO
Also covers: ACCD, AGL, AMWL +19 more
Gabrielle Ingoglia
Cantor Fitzgerald
1 question for DCGO
Also covers: ACHC, HCAT, TBRG +1 more
Jenny Shen
TD Cowen
1 question for DCGO
Also covers: AGL, CCSI, CYRX +8 more
Kieran Ryan
Deutsche Bank
1 question for DCGO
Also covers: AHCO, AVAH, BTSG +3 more
Michael Latimore
Northland Capital Markets
1 question for DCGO
Also covers: REKR, SYM
Richard Close
Canaccord Genuity Group
1 question for DCGO
Also covers: ACCD, AHCO, CLOV +15 more
Sarah James
Cantor Fitzgerald
1 question for DCGO
Also covers: ACHC, AMED, CI +15 more
Recent press releases and 8-K filings for DCGO.
DocGo Provides Business Update and 2025 Revenue Guidance
DCGO
Guidance Update
M&A
New Projects/Investments
- DocGo is a mobile healthcare company that delivers tech-driven medical care, including medical transportation, care-in-the-home, and remote patient monitoring, having served over 10 million patients since its inception.
- For Q3, the company reported $70.8 million in revenue, an Adjusted gross margin of 33%, and an Adjusted EBITDA loss of $7.2 million.
- DocGo issued 2025 revenue guidance of $280 million to $300 million, which is projected to triple the base business revenue over the past five years.
- The company recently acquired SteadyMD, an acquisition expected to improve gross margins by up to 10% and expand capacity for in-home visits by leveraging its network of hundreds of advanced practice providers across 50 states.
- DocGo maintains a strong balance sheet with $95.2 million in cash and no outstanding debt on its line of credit.
4 days ago
DocGo Inc. Highlights Q3 2025 Performance, 2026 Guidance, and Strategic Acquisition
DCGO
Guidance Update
M&A
Revenue Acceleration/Inflection
- DocGo Inc. reported Q3 2025 revenue of $70.8 million and an Adjusted EBITDA loss of $7.2 million, while maintaining a strong balance sheet with $95.2 million in cash and no outstanding debt.
- The company provided 2026 revenue guidance of $280 million to $300 million, noting this figure is based on existing customers and does not account for potential growth from new customers, markets, or M&A activities.
- DocGo recently acquired SteadyMD, a company expected to generate $25 million in revenue this year, to enhance its in-home visit model, with an anticipated gross margin improvement of up to 10% on deployment and support for expansion into new markets.
- For 2025, DocGo projects providing medical transportation for approximately 700,000 patients and care in the home for over 150,000 patients, driven by significant year-over-year growth in areas like Care Gap Closure and Transitional Care (320%).
4 days ago
DocGo Inc. Provides Q3 2025 Financials and FY 2026 Revenue Guidance
DCGO
Guidance Update
M&A
Revenue Acceleration/Inflection
- DocGo Inc. reported Q3 2025 revenue of $70.8 million, an adjusted gross margin of 33%, and an adjusted EBITDA loss of $7.2 million. The company maintains a strong balance sheet with $95.2 million in cash and no debt.
- The company issued revenue guidance for FY 2026 between $280 million and $300 million, noting this projection is based on existing customers and excludes potential new customers, markets, or M&A activities.
- DocGo recently acquired SteadyMD, a company expected to generate $25 million in revenue in 2025, which is anticipated to improve gross margins by up to 10% and expand capacity for its in-home visit model.
- The growth strategy emphasizes expanding with current payers, adding new payers, and entering new markets with existing customers, leveraging its vertically integrated, tech-driven mobile healthcare and medical transportation platform.
4 days ago
DocGo Discusses Strategic Acquisitions and Financial Transition at Southwest IDEAS Conference
DCGO
M&A
Guidance Update
Revenue Acceleration/Inflection
- DocGo (DCGO) provides mobile health and medical transportation services in the U.S. and U.K., leveraging a tech-driven mobile care platform.
- The company recently acquired SteadyMD in October 2025 to bolster its 50-state virtual care network and telehealth capabilities, and also acquired a mobile phlebotomy company earlier in 2025.
- For Q3 2025, DocGo reported revenue of $70.8 million - $71 million and an adjusted EBITDA loss of $7 million.
- DocGo is transitioning from non-recurring COVID and migrant-related revenues, with 2025 revenue projected at $320 million, down from over $600 million in 2024, though its core medical transportation business is expected to exceed $200 million in 2025, growing from $48 million in 2019.
- The company maintains a strong balance sheet with $95 million in total cash and generated positive operating cash flow of $45 million through the first nine months of 2025, driven by working capital improvements.
Nov 19, 2025, 7:20 PM
DocGo Discusses Strategic Shift and Q3 2025 Performance at Investor Conference
DCGO
Guidance Update
M&A
- DocGo's CFO, Norm Rosenberg, outlined the company's strategic shift away from non-recurring population health revenues, which peaked at over $600 million in 2023-2024, to a projected $320 million in 2025, driven by the growth of its core medical transportation and mobile health businesses.
- The company recently acquired SteadyMD in October 2025, which provides a 50-state virtual provider network and enables DocGo to vertically integrate telehealth with its in-home care services.
- DocGo reported Q3 2025 revenue of $70.8 million, an adjusted gross margin of 33%, and an adjusted EBITDA loss of $7 million.
- Despite a negative EBITDA of $18 million through the first nine months of 2025, DocGo generated $45 million in positive operating cash flow due to improved collection of accounts receivable, which had peaked at $280 million in Q1 2024. The company maintains a strong balance sheet with approximately $95 million in net cash and actively pursues M&A opportunities.
Nov 19, 2025, 7:20 PM
DocGo Reports Q3 2025 Results and Announces SteadyMD Acquisition
DCGO
Earnings
M&A
Guidance Update
- DocGo reported total revenue of $70.8 million and an Adjusted EBITDA loss of $7.2 million for Q3 2025, with a consolidated adjusted gross margin of 25.6%.
- The company acquired SteadyMD, gaining a 50-state virtual care clinical network expected to enhance in-home care, potentially improve gross margin by up to 10%, and be accretive to EBITDA in 2026.
- As of September 30, 2025, DocGo maintained a strong balance sheet with $95.2 million in total net cash and $353.8 million in total assets.
- DocGo projects significant growth in key metrics for 2025 and 2026, including 800,000 patients assigned for gap closure & TCM in 2025 and 3.5 million virtual care visits & lab orders in 2025.
- The company achieved record volumes across all major business lines in Q3 2025 compared to Q3 2024, notably a 320% increase in care gap closure and transitions of care.
Nov 12, 2025, 11:00 PM
DocGo Reports Q3 2025 Results and Provides 2026 Guidance
DCGO
Earnings
Guidance Update
M&A
- DocGo reported Q3 2025 revenue of $70.8 million and an Adjusted EBITDA loss of $7.1 million.
- The company updated its full-year 2025 revenue guidance to $315 million-$320 million and projected an Adjusted EBITDA loss of $25 million-$28 million.
- For 2026, DocGo anticipates revenue of $280 million-$300 million, reflecting 12%-20% year-over-year base business growth, and an Adjusted EBITDA loss of $15 million-$25 million, with an expectation to exit the year Adjusted EBITDA positive at the top end of revenue guidance.
- DocGo acquired SteadyMD, a virtual care provider, which is projected to contribute $25 million to 2026 payer and provider revenue.
- The company strengthened its balance sheet by becoming debt-free as of Q3 2025 after paying off its outstanding line of credit, holding $95.2 million in cash and cash equivalents.
Nov 10, 2025, 10:00 PM
DCGO Announces Q3 2025 Results and Provides 2026 Guidance
DCGO
Earnings
Guidance Update
M&A
- DocGo reported Q3 2025 total revenue of $70.8 million, with non-migrant revenue increasing 8% to $62.4 million year-over-year, and an adjusted EBITDA loss of $7.1 million.
- The company expects full-year 2025 revenue between $315 million and $320 million and an adjusted EBITDA loss of $25 million to $28 million. For 2026, revenue guidance is $280 million to $300 million, representing 12%-20% growth over 2025 base revenues, with an anticipated adjusted EBITDA loss of $15 million to $25 million.
- DocGo highlighted the acquisition of SteadyMD, which is expected to contribute $5 million to 2025 and $25 million to 2026 payer and provider revenue. The company also reported a debt-free balance sheet as of Q3 2025.
Nov 10, 2025, 10:00 PM
DocGo Announces Third Quarter 2025 Results and Updates Full-Year Guidance
DCGO
Earnings
Guidance Update
Revenue Acceleration/Inflection
- DocGo reported total revenue of $70.8 million for the third quarter of 2025, a decline from $138.7 million in the third quarter of 2024, primarily due to the wind-down of migrant-related programs. Excluding migrant-related programs, revenue increased 8% to $62.4 million.
- The company recorded a net loss of $29.7 million and an adjusted EBITDA loss of $7.2 million for Q3 2025, compared to net income of $4.5 million and adjusted EBITDA of $17.9 million in Q3 2024. The net loss included $16.7 million of non-cash impairments.
- As of September 30, 2025, DocGo held approximately $95.2 million in cash and cash equivalents and generated $1.7 million of cash flow from operations during the quarter.
- For full-year 2025, the company expects revenue between $315 million and $320 million and an adjusted EBITDA loss of $25 million to $28 million.
- Full-year 2026 revenue is projected to be $280 million to $300 million, which includes no migrant-related revenue, with an anticipated adjusted EBITDA loss of $15 million to $25 million.
Nov 10, 2025, 9:07 PM
DocGo Announces Third Quarter 2025 Results
DCGO
Earnings
Guidance Update
M&A
- DocGo reported total revenue of $70.8 million for the third quarter of 2025, a decrease from $138.7 million in the third quarter of 2024, primarily due to the wind-down of migrant-related programs. Excluding revenue from migrant-related programs, revenue increased 8% to $62.4 million.
- The company recorded a net loss of $29.7 million and an Adjusted EBITDA loss of $7.2 million for Q3 2025, compared to net income of $4.5 million and Adjusted EBITDA of $17.9 million in Q3 2024, respectively. The net loss included $16.7 million of non-cash impairments.
- As of September 30, 2025, DocGo held cash and cash equivalents of approximately $95.2 million, a decline from $128.7 million as of June 30, 2025, largely due to the repayment of a $30 million line of credit. The company generated $1.7 million of cash flow from operations during Q3 2025.
- DocGo updated its full-year 2025 revenue guidance to $315-$320 million and its full-year 2025 adjusted EBITDA guidance to a loss of $25-$28 million.
- For full-year 2026, the company expects revenue of $280-$300 million (with no migrant-related revenue) and an adjusted EBITDA loss of $15-$25 million. Subsequent to quarter end, DocGo acquired virtual care platform SteadyMD.
Nov 10, 2025, 9:05 PM
Quarterly earnings call transcripts for DocGo.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more